首页> 外国专利> Compound 1,1 dioxide - penicillanic acid without Therapeutic activity.Useful as Intermediates for preparing beta lactamase inhibitors and Method for producing such beta lactamase Inhibitors, based on such intermediaries

Compound 1,1 dioxide - penicillanic acid without Therapeutic activity.Useful as Intermediates for preparing beta lactamase inhibitors and Method for producing such beta lactamase Inhibitors, based on such intermediaries

机译:化合物1,1-二氧化青霉酸,无治疗活性。可用作制备β-内酰胺酶抑制剂的中间体,以及基于此类中间体的生产β-内酰胺酶抑制剂的方法

摘要

A process for the preparation of penicillanic acid 1,1-dioxide and esters thereof readily hydrolyzable in vivo. Said process involves dehalogenation of a 6-halo or 6,6-dihalo derivative of penicillanic acid 1,1-dioxide or ester thereof readily hydrolyzable in vivo or a carboxy protected derivative thereof (e.g. by hydrogenolysis). The 6-halo and 6,6-dihalo derivatives of penicillanic acid 1,1-dioxides, esters thereof readily hydrolyzable in vivo, and carboxy protected derivatives thereof are novel intermediates. Penicillanic acid 1,1-dioxide, and esters thereof readily hydrolyzable in vivo, are known compounds which are useful as beta- lactamase inhibitors and for enhancing the effectiveness of certain beta-lactam antibiotics (e.g. the penicillins) in the treatment of bacterial infections in mammals, particularly humans.
机译:一种在体内易于水解的青霉酸1,1-二氧化物及其酯的制备方法。所述方法涉及青蒿酸1,1-二氧化物或其中间体在体内易于水解的6-卤或6,6-二卤衍生物或其羧基保护的衍生物(例如通过氢解)的脱卤作用。青霉酸1,1-二氧化物的6-卤和6,6-二卤衍生物,其在体内易于水解的酯以及其羧基保护的衍生物是新型中间体。青霉酸1,1-二氧化物及其酯在体内易于水解,是已知的化合物,可用作β-内酰胺酶抑制剂并增强某些β-内酰胺类抗生素(如青霉素)在治疗细菌感染中的功效。哺乳动物,特别是人类。

著录项

  • 公开/公告号AR225031A1

    专利类型

  • 公开/公告日1982-02-15

    原文格式PDF

  • 申请/专利权人 PFIZER INC;

    申请/专利号AR19800280148

  • 发明设计人

    申请日1980-03-03

  • 分类号C07D499/00;

  • 国家 AR

  • 入库时间 2022-08-22 13:57:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号